Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Galectin-related inter-fiber protein (GRIFIN) is a soluble, highly abundant protein in the vertebrate lens, particularly in lens fiber cells. While structurally related to galectins—a family of β-galactoside-binding lectins—GRIFIN in mammals lacks key residues for carbohydrate binding and does not function as an authentic galectin. This functional divergence suggests GRIFIN is a result of evolutionary co-option: it likely evolved from a carbohydrate-binding ancestor (such as galectin-3) into a lens crystallin, losing lectin activity but acquiring or emphasizing a structural role to maintain lens transparency. In zebrafish and some other non-mammalian species, homologous GRIFIN variants retain carbohydrate binding and galectin-like activity, suggesting a broader functional diversity across species. In addition to its structural role, GRIFIN can interact with other major lens proteins such as α-crystallin, suggesting a role in maintaining lens protein organization and solubility. Currently, GRIFIN is not established as a drug target, biomarker, or therapeutic focus.
None reported; not a known drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Galectin-related inter-fiber protein (GRIFIN).